Basit öğe kaydını göster

Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

dc.contributor.authorEmet, Samim
dc.contributor.authorOncul, Aytac
dc.contributor.authorOnur, Imran
dc.contributor.authorMercanoglu, Fehmi
dc.contributor.authorYilmaz, Mustafa
dc.contributor.authorElitok, Ali
dc.contributor.authorCakir, Mustafa Ozan
dc.contributor.authorAdalet, Kamil
dc.contributor.authorBilge, Ahmet Kaya
dc.contributor.authorDadashov, Mubariz
dc.contributor.authorSonsoz, Mehmet Rasih
dc.date.accessioned2021-03-03T09:20:06Z
dc.date.available2021-03-03T09:20:06Z
dc.date.issued2018
dc.identifier.citationEmet S., Dadashov M., Sonsoz M. R. , Cakir M. O. , Yilmaz M., Elitok A., Bilge A. K. , Mercanoglu F., Oncul A., Adalet K., et al., "Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy.", The American journal of the medical sciences, cilt.356, sa.6, ss.537-543, 2018
dc.identifier.issn0002-9629
dc.identifier.othervv_1032021
dc.identifier.otherav_1c779997-8160-4cd5-be42-03c49a6742b9
dc.identifier.urihttp://hdl.handle.net/20.500.12627/24382
dc.identifier.urihttps://doi.org/10.1016/j.amjms.2018.08.013
dc.description.abstractBackground: Hypertrophic cardiomyopathy is a primary cardiac disease characterized by left ventricular hypertrophy, myocyte hypertrophy and irregularities and interstitial fibrosis in the absence of any cardiac or systemic diseases and may lead to sudden cardiac death (SCD). Galectin-3 is a P-galactoside-binding lectin that has been associated with cardiac fibrosis and inflammation. In this study, we aimed to investigate the relationship between serum galectin-3 levels and the criteria for 5-year sudden death risk, recently defined in the European Society of Cardiology guidelines (2014), in patients with hypertrophic cardiomyopathy.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.titleGalectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
dc.typeMakale
dc.relation.journalThe American journal of the medical sciences
dc.contributor.departmentZonguldak Bülent Ecevit Üniversitesi , ,
dc.identifier.volume356
dc.identifier.issue6
dc.identifier.startpage537
dc.identifier.endpage543
dc.contributor.firstauthorID84773


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster